Dashboard
Manage Tickers

ETON


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

eton-pharmaceuticals-q2-adj-eps-010-misses-005-estimate-sales-1893m-beat-1660m-estimate
Eton Pharmaceuticals Q2 Adj. EPS $(0.10) M...
08/07/2025 20:06:08

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate o...

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

the-fda-has-accepted-eton-pharmaceuticals-new-drug-application-for-et-600-a-proprietary-patented-formulation-of-desmopressin-oral-solution-for-review-and-assigned-a-prescription-drug-user-fee-act-target-action-date-of-february-25-2026
The FDA Has Accepted Eton Pharmaceuticals'...
07/08/2025 10:52:49

ET-600 is a proprietary formulation of desmopressin oral solution developed for the treatment of central diabetes insipidius, a...

eton-pharmaceuticals-to-join-russell-2000-and-3000-indexes-after-june-27-market-close
Eton Pharmaceuticals To Join Russell 2000 ...
06/27/2025 10:51:23

fda-approves-eton-pharmas-oral-drug-for-adrenal-insufficiency-in-pediatric-patients-analyst-sees-boost-in-2025-revenue
FDA Approves Eton Pharma's Oral Drug For A...
05/29/2025 16:42:18

Eton Pharma's Khindivi has won FDA approval as a pediatric adrenal insufficiency treatment. It is projected to surge in sal...

hc-wainwright--co-maintains-buy-on-eton-pharmaceuticals-raises-price-target-to-35
HC Wainwright & Co. Maintains Buy on Eton ...
05/29/2025 11:12:07

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises th...

eton-pharmaceuticals-receives-us-fda-approval-for-khindivi-oral-solution
Eton Pharmaceuticals Receives U.S. FDA App...
05/28/2025 21:29:54

b-riley-securities-reiterates-buy-on-eton-pharmaceuticals-raises-price-target-to-26
B. Riley Securities Reiterates Buy on Eton...
05/16/2025 17:17:14

B. Riley Securities analyst Madison El-Saadi reiterates Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price t...

a-glimpse-into-the-expert-outlook-on-eton-pharmaceuticals-through-4-analysts
A Glimpse Into The Expert Outlook On Eton ...
05/14/2025 18:01:09

craig-hallum-maintains-buy-on-eton-pharmaceuticals-raises-price-target-to-28
Craig-Hallum Maintains Buy on Eton Pharmac...
05/14/2025 17:43:40

Craig-Hallum analyst Chase Knickerbocker maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target...

eton-pharmaceuticals-q1-adj-eps-007-beats-005-estimate-sales-1728m-beat-1513m-estimate
Eton Pharmaceuticals Q1 Adj. EPS $0.07 Bea...
05/13/2025 20:05:31

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of ...

Core News & Articles
Earnings Scheduled For May 13, 2025
05/13/2025 08:32:43

a-look-ahead-eton-pharmaceuticalss-earnings-forecast
A Look Ahead: Eton Pharmaceuticals's Earni...
05/12/2025 14:03:13

eton-pharma-submits-nda-to-fda-for-proprietary-desmopressin-oral-solution-et-600-anticipates-q1-2026-launch-after-10-month-review
Eton Pharma Submits NDA To FDA For Proprie...
04/28/2025 10:53:41

- NDA submitted for the treatment of central diabetes insipidus -- Expected 10-month review; commercial preparations underway f...

eton-pharmaceuticals-out-incenses-commercial-rights-to-increlex-in-territories-outside-of-the-us-to-esteve-pharmaceuticals
Eton Pharmaceuticals Out-Incenses Commerci...
04/01/2025 11:07:26

craig-hallum-maintains-buy-on-eton-pharmaceuticals-raises-price-target-to-26
Craig-Hallum Maintains Buy on Eton Pharmac...
03/19/2025 16:16:04

Craig-Hallum analyst Chase Knickerbocker maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target...

b-riley-securities-reiterates-buy-on-eton-pharmaceuticals-raises-price-target-to-24
B. Riley Securities Reiterates Buy on Eton...
03/19/2025 15:49:02

B. Riley Securities analyst Madison El-Saadi reiterates Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price t...

5-analysts-assess-eton-pharmaceuticals-what-you-need-to-know
5 Analysts Assess Eton Pharmaceuticals: Wh...
03/19/2025 13:00:59

hc-wainwright--co-reiterates-buy-on-eton-pharmaceuticals-maintains-33-price-target
HC Wainwright & Co. Reiterates Buy on Eton...
03/19/2025 10:29:02

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and maintain...

eton-pharmaceuticals-q4-2024-gaap-eps-002-vs-009-yoy-sales-1165m-beat-1053m-estimate
Eton Pharmaceuticals Q4 2024 GAAP EPS $(0....
03/18/2025 10:51:53

V

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION